By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The US Food and Drug Administration has cleared a test developed by the US Centers for Disease Control and Prevention for the diagnosis in humans of the 2009 H1N1 Influenza, making it the second to receive clearance, CDC said on Tuesday.

The test, called the CDC Influenza 2009 A (H1N1) pdm Real-Time PCR Panel, replaces an earlier test by CDC, also based on real-time RT-PCR technology, which received emergency authorization by the FDA in April, 2009.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Fareed Zakaria writes that instead of focusing solely on STEM-related courses, students would do well to pursue the liberal arts if they want to be technology innovators.

A Harvard Business Review study found four major patterns of gender biases and added that black and Latina scientists further had to navigate racial stereotypes.

In PLOS this week: variant linked to canine cleft lip, new compression tool, and more.

GNC will start using DNA testing to authentic the presence of plants included in its labels, following an agreement with the New York Attorney General.